Medical Properties Trust, Inc. (NYSE: MPT) Stock Analysis & Fundamentals

MPTMedical Properties Trust, Inc.

NYSE · US · Real Estate · REIT - Healthcare Facilities · medicalpropertiestrust.com

4.820USD+2.77%Mkt Cap: 2.88B $P/E: —1d ago

Medical Properties Trust, Inc. is a self-advised real estate investment trust to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the w…

Industry Peers

REIT - Healthcare Facilities

Omega Healthcare Investors, Inc.

$15.55BUSDP/E 24.1

DOC

Healthpeak Properties, Inc.

Healthcare Realty Trust Incorporated

Chartwell Retirement Residences

$5.42BUSDP/E Infinity

SBRA

Sabra Health Care REIT, Inc.

$5.08BUSDP/E 32.0

NHI

National Health Investors, Inc.

$3.84BUSDP/E 25.5

PHP

Primary Health Properties Plc

$2.62BUSDP/E 13.3

DHC

Diversified Healthcare Trust

National Healthcare Properties, Inc.

$1.15BUSD

CPINV

Care Property Invest NV

$585.39MUSDP/E 8.4

UHT

Universal Health Realty Income Trust

$607.75MUSDP/E 34.2

XRN

Chiron Real Estate Inc.

$598.43MUSD

CHCT

Community Healthcare Trust Incorporated

$530.86MUSDP/E 154.8

STRW

Strawberry Fields REIT, Inc.

$184.88MUSDP/E 21.5

Indicators:|

Key Statistics

Company

Market Cap2.88B $

Enterprise Value12.12B $

Revenue (TTM)1.10B $

Gross Profit935.61M $

Net Income (TTM)-277.05M $

Revenue/Share1.833 USD

Last Price4.820 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees121

CountryUS

SectorReal Estate

IndustryREIT - Healthcare Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)32.86

PEG1.61

EV/EBITDA12.76

EV/Revenue11.02

P/S2.62

P/B0.63

EPS (TTM)-0.21

EPS (Forward)0.15

52W Range

3.95035% of range6.470

52W High6.470 USD

52W Low3.950 USD

Profitability

Gross Margin96.25%

Oper. Margin58.23%

EBITDA Margin86.38%

Profit Margin-28.50%

ROE-6.01%

ROA-1.85%

Growth

Revenue Growth12.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF230.77M $

CapEx (TTM)—

FCF Margin71.11%

FCF Yield27.13%

Net Debt9.24B $

Net Debt/EBITDA9.72

Balance Sheet

Debt/Equity2.13

Current Ratio1.18

Quick Ratio1.03

Book Value/Sh7.603 USD

Cash/Share0.7110 USD

Dividends

Fwd Div Rate0.3600 USD

Trail. Div Rate0.3400 USD

Div. Yield7.68%

5Y Avg Yield10.13%

Payout Ratio1054.55%

Ex-Div DateJun 18, 2026

Pay DateJul 16, 2026

Analyst Consensus

Rating3.1 (Hold)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)5.714 USD

Upside (mean)+18.6%

Target Range4.500 USD – 8.000 USD

$4.500+18.6% to mean$8.000

# Analysts7

Ownership

Shares Out.598.10M

Float490.65M

Insiders17.52%

Institutions59.91%

Short Interest

Short Ratio20.5d

Short % Float30.89%

Short % Out.23.09%

Shares Short138.11M

Short (prev mo.)133.17M

Technical

SMA 504.860 (-0.8%)

SMA 2005.095 (-5.4%)

Beta1.46

S&P 52W Chg19.63%

Avg Vol (30d)5.79M

Avg Vol (10d)5.93M

Technical Indicators

RSI (14)57.1

MACD-0.0522

MACD Signal-0.0920

MACD Hist.+0.0398

BB Upper4.780 USD

BB Middle4.569 USD

BB Lower4.358 USD

BB Width9.24%

ATR (14)0.1494 USD

Vol Ratio (20d)0.77x